天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Shanghai Yifei Biotechnology Co. , Ltd.

Firmenname:Shanghai Yifei Biotechnology Co. , Ltd.
Telefon:021-65675885
E-Mail:customer_service@efebio.com
Nationalit?t:China
URL: http://www.efebio.com
Produkte insgesamt:11973
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

Produktkatalog

Navivumab1443004-16-7
Trevogrumab1429201-24-0
Lanadelumab1426055-14-2
IHVR-170281428247-78-2C23H44N2O5
Calpain-2-IN-1144231-85-6C28H37N3O7
IND241426047-44-0C21H17N3S
PI3Kδ-IN-31431540-99-6C28H24N6O3
Tafasitamab1422527-84-1
Bermekimab1401965-15-8
Romilkimab1399584-78-1
Luvadaxistat1425511-32-5C13H11F3N2O2
WIN 51,708144177-30-0C29H33N3O
Phenanthriplatin1416900-51-0C13H13ClN4O3Pt
Xentuzumab1417158-65-6
Uplarafenib1425485-87-5C22H21F3N4O4S
ZD-2138140841-32-3C23H24FNO4
JAK-IN-31400876-94-9C18H20N4O3
Ralpancizumab1407495-04-8
Opicinumab1422268-07-2
Tisotumab1418628-81-5
Quetiapine-d8 Hemifumarate1435938-24-1C25H29N3O6S
H4R antagonist 11429375-54-1C11H11BrN8
Tenatumomab1412891-40-7
Dapirolizumab pegol1416147-64-2
Firivumab1443004-15-6
Usenamine A1428417-60-0C18H17NO6
14-Epiandrographolide142037-79-4C20H30O5
Glutaminase-IN-31439399-45-7C19H19F3N6O2S
Pasotuxizumab1442657-12-6
Begelomab1403744-56-8
EN33561429329-63-4C16H13FN2OS
HXJ421428640-39-4C15H15Cl2N5O
Bococizumab1407495-02-6
Utomilumab1417318-27-4
MM-401 TFA1442106-11-7C31H47F3N8O7
Lapisteride142139-60-4C29H40N2O3
Carbaryl-d31433961-56-8C12H11NO2
Lanopepden mesylate1441390-17-5C23H38FN7O7S
Sofituzumab vedotin1418200-58-4
GSK572A1403602-32-3C22H21F4N5O
Sinitrodil143248-63-9C10H10N2O5
(S)-Baxdrostat1428652-16-7C22H25N3O2
Rofleponide144459-70-1C25H34F2O6
Amino-Tri-(carboxyethoxymethyl)-methane hydrochloride1416771-72-6C13H24ClNO9
STL12671429024-58-7C17H11ClN4O
Muromonab140608-64-6
Acetazolamide sodium2-Acetylamino-1,3,4-thiadiazol-5-sulfonamid, Natriumsalz1424-27-7C4H7N4NaO3S2
Pritelivir mesylate hydrate1428321-10-1C19H22N4O6S3
Lifastuzumab vedotin1401812-88-1
Lulizumab pegol1421830-13-8
Imalumab1430205-07-4
3,3-Dimethylbutanoic acid-d91399294-95-1C6H12O2
RP 61499143680-27-7C12H16N2OS2
Psiguadial D1402066-95-8C30H34O5
VUF-112221414376-84-3C25H31BrIN
VU 04696501443748-47-7C22H28N4O
Safingol hydrochloride139755-79-6C18H39NO2. HCl
ML 3151440251-53-5C18H13Cl2N3O2
PR-9241416709-79-9C37H38N4O5
Labuxtinib1426449-01-5C20H16FN5O2
SiR-COOH1418275-26-9C27H28N2O4Si
GRGDSPK acetate144027-77-0
BI-9627 hydrochloride1422252-46-7C16H20ClF3N4O2
PIM1-IN-11417630-95-5C25H30N8O2
N 0861141696-90-4C13H17N5
Org-13011 fumarate142494-13-1C22H29F3N4O5
TRPV3 antagonist 74a1432051-63-2C17H17F3N2O2
1-[4-(1H-Imidazol-1-yl)phenyl]methanamine dihydrochloride1431966-12-9C10H12ClN3
PF-033827921400811-63-3C23H32FN3O4
TWIK-1/TREK-1-IN-31440532-33-1C19H27F3N2O2
APOBEC3G-IN-114261-92-8C15H11NO3
CKD-5191402796-27-3C31H34F7NO3
Silperisone HCl140944-30-5C15H25ClFNSi
MPO-IN-31435469-45-6C16H22ClN3O3S
SPH31271399849-02-5C22H32N6O4
RS 56812143137-37-5C18H21N3O2
Larotinib1438072-11-7C24H26ClFN4O4
Org 13011142494-12-0C18H25F3N4O
Eldacimibe141993-70-6C39H58N2O5
Vevorisertib trihydrochloride1416775-08-0C35H39ClN8O
Sonelokimab1414386-05-2
IRE1α kinase-IN-21414938-21-8C27H23F3N6O
Edobacomab141410-98-2
Enlimomab142864-19-5
Dynole 2-241416313-72-8C24H41N3
RapiFluor-MS1429047-69-7C21H25N5O5
EZH2-IN-131403255-41-3C34H45N5O3
Tentoxin-d31426437-58-2C22H30N4O4
TNIK-IN-71417795-24-4C23H22N4O2
Antitumor agent-871422527-88-5C22H28N2O6S
Vamotinib1416241-23-0C29H27F3N6O
Triptoquinone A142950-86-5C20H24O4
TINK-IN-11417795-25-5C24H24N4O3
ERG2401415683-79-2C7H13NaO3
ME-3221139958-16-0C22H21N5O2
Sovleplenib1415792-84-5C24H30N6O3S
Dimethylaminomicheliolide HCl1403357-80-1C17H28ClNO3
BMS-9632721441057-15-3C24H21F6N5O2
Lirequinil143943-73-1C26H25ClN2O3
isomer-GAT 1071426240-47-2C18H17BrN2O2S
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2019 ? ChemicalBook. All rights reserved